Today Announceda Poster Presentation From The Ongoing Biomarkers Of Progression In Multiple System Atrophy Biomuse Natural History Study Was Given At American Autonomic Society Aas 2022 Annual Conference Held November 2 5 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MELBOURNE, Australia and SAN FRANCISCO, Nov. 7, 2022 /PRNewswire/ Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases,today announced a poster presentation from the ongoing Biomarkers of Progression in Multiple System Atrophy (bioMUSE) natural history study was given at the American Autonomic Society (AAS) 2022 Annual Conference held November 2-5, 2022. Multiple System Atrophy (MSA) is a progressive neurodegenerative disease that presents with motor and prominent autonomic symptoms. Major sources of disability in MSA result from motor symptoms characteristic of Parkinson's disease and impaired ability to maintain normal blood pressure, bowel function and bladder control. Problems with urination are a common symptom experienced in MSA and can occur at any time during the disease process. The poster, entitled, Urinary Symptom Profi ....

United States , San Francisco , Daniel Claassen , David Stamler , Vanderbilt University Medical Center , National Institute Of Health , American Autonomic Society , European Commission , Alterity Therapeutics , Multiple System Atrophy , System Atrophy , Urinary Symptom Profile , Early Multiple System Atrophy , Chief Executive Officer , Associate Professor , Neurological Disorders , Multiple System Atrophy Fact , Ustralia And San Francisco , Nov 7 , 022 Prnewswire Alterity Therapeutics Asx Ath , Asdaq Athe Quot Alterity Or The Company , A Biotechnology Company Dedicated To Developing Disease Modifying Treatments For Neurodegenerative Diseases , Today Announceda Poster Presentation From The Ongoing Biomarkers Of Progression In Multiple System Atrophy Biomuse Natural History Study Was Given At American Autonomic Society Aas 2022 Annual Conference Held November 2 5 , 022 Multiple System Atrophy Msa Isa Progressive Neurodegenerative Disease That Presents With Motor And Prominent Autonomic Symptoms Major Sources Of Disability In Result From Characteristic Parkinson 39s Impaired Ability To Maintain Normal Blood Pressure , Owel Function And Bladder Control Problems With Urination Area Common Symptom Experienced In Msa Can Occur At Any Time During The Disease Process Poster , Rinary Symptom Profile In Early Multiple System Atrophy ,